Lenalidomide or Pomalidomide
HM16/118
Phase 1 small_molecule active
Quick answer
Lenalidomide or Pomalidomide for Multiple Myeloma is a Phase 1 program (small_molecule) at ONCOLYTICS BIOTECH INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ONCOLYTICS BIOTECH INC
- Indication
- Multiple Myeloma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active